1335 related articles for article (PubMed ID: 29566670)
1. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
2. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
3. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Kovi RC; Bhusari S; Mav D; Shah RR; Ton TV; Hoenerhoff MJ; Sills RC; Pandiri AR
Arch Toxicol; 2019 Aug; 93(8):2219-2235. PubMed ID: 31278416
[TBL] [Abstract][Full Text] [Related]
5. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation analysis in hepatocellular carcinoma.
Yamada N; Yasui K; Dohi O; Gen Y; Tomie A; Kitaichi T; Iwai N; Mitsuyoshi H; Sumida Y; Moriguchi M; Yamaguchi K; Nishikawa T; Umemura A; Naito Y; Tanaka S; Arii S; Itoh Y
Oncol Rep; 2016 Apr; 35(4):2228-36. PubMed ID: 26883180
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
Fujiwara K; Ghosh S; Liang P; Morien E; Soma M; Nagase H
Mol Carcinog; 2015 Mar; 54(3):178-88. PubMed ID: 24115114
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.
Zhai JM; Yin XY; Hou X; Hao XY; Cai JP; Liang LJ; Zhang LJ
Dig Dis Sci; 2013 Jul; 58(7):1934-47. PubMed ID: 23625283
[TBL] [Abstract][Full Text] [Related]
14.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
19. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]